AGP Picks
View all

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on November 3, 2026

Pasithea Therapeutics Announces FDA Clearance of IND for PAS-004 in Neurofibromatosis Type 1 (NF1)-Associated Cutaneous Neurofibromas (cNF)
Hemab Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 10, 2026
Jade Biosciences to Participate in Upcoming Conferences
The great housing adaptation - Canadians are adapting, not abandoning, homeownership goals
Rapport Therapeutics to Participate in Upcoming Investor Conferences
BlossomHill Therapeutics to Present at Guggenheim’s  3rd Annual Healthcare Innovations Conference
NexGold Intersects 4.16 g/t Gold over 7.0 Metres, 2.84 g/t Gold over 7.0 Metres and 1.94 g/t Gold over 9.0 Metres in RC Infill Drill Program at the Goldboro Gold Project, Nova Scotia
Rhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update
C4 Therapeutics to Participate in Upcoming November Investor Conferences
Oruka Therapeutics to Participate in Multiple Upcoming Conferences
Arvinas Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November
ProMIS Neurosciences to Report Third Quarter 2026 Financial Results and Business Update on November 12, 2026
Envoy Technologies Expands into Southwest Florida with EV Car Sharing at $100 Million Midtown Redevelopment
Shopify Sustains Rapid Growth with Revenue Up 32% and Free Cash Flow Margin of 22%
Aurora Mobile's EngageLab Partners with SKYWORTH Solar to Support Global Channel Operations and Project Delivery with AppPush
QUANTRO Therapeutics secures key Austrian research grant to build its AI-powered drug discovery platform
InflaRx Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day
Seres Therapeutics Announces Publication of SER-155 Phase 1b Results in Nature Medicine Showing Reduced Bloodstream Infections in Allogeneic Hematopoietic Cell Transplantation Recipients
Kura Oncology to Report Third Quarter Financial Results on November 10

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

STEM News Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.